SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Net Sales | ₹263 Cr | ₹224 Cr | ₹220 Cr | ₹18,482,242 Cr | ₹184 Cr |
What is the latest Revenue of SYNCOM FORMULATIONS (INDIA) ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹263 Cr |
| Mar2024 | ₹224 Cr |
| Mar2023 | ₹220 Cr |
| Mar2022 | ₹18,482,242 Cr |
| Mar2017 | ₹184 Cr |
How is Revenue of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹263 Cr | 17.45 | |
| Mar2024 | ₹224 Cr | 2.09 | |
| Mar2023 | ₹220 Cr | -100.00 | |
| Mar2022 | ₹18,482,242 Cr | 10,050,222.98 | |
| Mar2017 | ₹184 Cr | - | |
Compare Revenue of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,356.4 Cr | -0.6% | -8.2% | -27.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -0.6% |
-8.2% |
-27.1% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses